Moore Capital Management »

Bridgebio Pharma shares owned by Moore Capital Management

Quarter-by-quarter ownership of Bridgebio Pharma shares owned by Moore Capital Management from 13F filings

Historical chart of Moore Capital Management investment in Bridgebio Pharma

Tip: Access up to 7 years of quarterly data

All positions including Bridgebio Pharma held by Moore Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Bridgebio Pharma by Moore Capital Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $57M 32M 1.78

More positions owned by Moore Capital Management

Ishares Tr 20 Yr Tr Bd Etf (TLT)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Ishares Tr Russell 2000 Etf (IWM)
NVIDIA Corporation (NVDA)
Ubs Group SHS (UBS)
Applied Materials (AMAT)
Hut 8 Corp (HUT)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Ishares Tr 7-10 Yr Trsy Bd (IEF)
Regal-beloit Corporation (RRX)
Devon Energy Corporation (DVN)
Apollo Global Mgmt (APO)
Lam Research Corp Com New (LRCX)
Citigroup Com New (C)
Bloom Energy Corp Com Cl A (BE)

View all positions for Moore Capital Management

Top funds holding Bridgebio Pharma

Wolverine Asset Management
Steelhead Partners
Capstone Investment Advisors
DeepCurrents Investment Group
Moore Capital Management
Aristeia Capital
Lazard Asset Management
Graham Capital Management
683 Capital Management
Millennium Management
Bnp Paribas Arbitrage, Snc
Bank of America Corporation
State Street Corporation
M&G
BlackRock

View all funds holding Bridgebio Pharma